Percheron Therapeutics (ASX:PER) Accumulated Depreciation : A$0.00 Mil (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Percheron Therapeutics Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Percheron Therapeutics's quarterly accumulated depreciation increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$-0.59 Mil) but then stayed the same from Jun. 2023 (A$-0.59 Mil) to Dec. 2023 (A$0.00 Mil).

Percheron Therapeutics's annual accumulated depreciation increased from Jun. 2021 (A$-0.40 Mil) to Jun. 2022 (A$-0.49 Mil) and increased from Jun. 2022 (A$-0.49 Mil) to Jun. 2023 (A$-0.59 Mil).

Percheron Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Percheron Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Percheron Therapeutics Accumulated Depreciation Chart

Percheron Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Accumulated Depreciation

Get a 7-Day Free Trial

-0.19

-0.30

-0.40

-0.49

-0.59

Percheron Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accumulated Depreciation	Get a 7-Day Free Trial															-	-0.49	-	-0.59	-

Percheron Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Percheron Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Percheron Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Percheron Therapeutics (ASX:PER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Percheron Therapeutics Ltd (ASX:PER) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

ATHJF:USA AWY0:Germany

Address

14 Wallace Avenue, Toorak, VIC, AUS, 3142

Website

https://www.antisense.com.au

Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals. The company operates in two segments that have been identified based on its antisense oligonucleotide products as ATL1102 and ATL1103.

Percheron Therapeutics (ASX:PER) Headlines

No Headlines